IP vs NRIX
International Paper (IP) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the IP and NRIX stock pages for the full models.
Not investment advice.